Abstract
In the 21st century, humans are in the battle against a deadly contagious disease COVID-19, first reported in Wuhan, China. Coronavirus disease, designated as COVID-19, is caused by SARS CoV-2 virus from the beta coronavirus family. Although there are no specific anti- viral drugs and vaccines against this pandemic disease, however, many medicines are being repurposed for COVID-19 management but have shown limited success. Traditional medicine systems, since ancient time, were used for their immense efficacy with minimal adverse effects compared to allopathic medicines. Thus, for COVID-19 management, researchers are focusing on traditional medicines from Ayurveda, Chinese medicine, Unani, Siddha, and Homeopathy as adjuvant therapy as per anecdotal data regarding their use in the treatment of infectious disease. In India, all the traditional medicine systems are under AYUSH ministry and government has been highlighting AYSUH medicines for improving immune system against COVID-19. In this review, the authors emphasize on the historical background of AYUSH medicines in the prevention and treatment of infectious diseases and the medicines recommended by the AYUSH ministry for combating COVID-19 as immunity boosters.
Keywords: COVID-19, AYUSH, traditional medicine, SARS CoV-2, ayurveda, homeopathy, siddha, unani.
Current Traditional Medicine
Title:AYUSH Preparations as Immunity Booster in the Management of SARS - CoV-2: A Review
Volume: 7 Issue: 4
Author(s): Suneel Prajapati*, Mahima Sharma, Arun Kumar, Ashish Tripathi, GV Narasimha Kumar, Shilpi Singh, Monika Singh, Digvijay Verma and Pankaj Gupta
Affiliation:
- Central Forensic Science Laboratory, Krishna Complex, Kharadi, Pune, Maharashtra,India
Keywords: COVID-19, AYUSH, traditional medicine, SARS CoV-2, ayurveda, homeopathy, siddha, unani.
Abstract: In the 21st century, humans are in the battle against a deadly contagious disease COVID-19, first reported in Wuhan, China. Coronavirus disease, designated as COVID-19, is caused by SARS CoV-2 virus from the beta coronavirus family. Although there are no specific anti- viral drugs and vaccines against this pandemic disease, however, many medicines are being repurposed for COVID-19 management but have shown limited success. Traditional medicine systems, since ancient time, were used for their immense efficacy with minimal adverse effects compared to allopathic medicines. Thus, for COVID-19 management, researchers are focusing on traditional medicines from Ayurveda, Chinese medicine, Unani, Siddha, and Homeopathy as adjuvant therapy as per anecdotal data regarding their use in the treatment of infectious disease. In India, all the traditional medicine systems are under AYUSH ministry and government has been highlighting AYSUH medicines for improving immune system against COVID-19. In this review, the authors emphasize on the historical background of AYUSH medicines in the prevention and treatment of infectious diseases and the medicines recommended by the AYUSH ministry for combating COVID-19 as immunity boosters.
Export Options
About this article
Cite this article as:
Prajapati Suneel *, Sharma Mahima, Kumar Arun , Tripathi Ashish , Kumar Narasimha GV , Singh Shilpi , Singh Monika, Verma Digvijay and Gupta Pankaj , AYUSH Preparations as Immunity Booster in the Management of SARS - CoV-2: A Review, Current Traditional Medicine 2021; 7 (4) : e190122188623 . https://dx.doi.org/10.2174/2215083806999201202151923
DOI https://dx.doi.org/10.2174/2215083806999201202151923 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy
Current Gene Therapy A Review of the English and Russian Language Literature on the Osteoarticular Manifestations of Brucellosis Infection
Current Rheumatology Reviews An Update on JAK Inhibitors
Current Medicinal Chemistry Immunostimulatory Oligonucleotides
Recent Patents on Inflammation & Allergy Drug Discovery Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Fatty Acid-Binding Proteins at a Glance
Protein & Peptide Letters The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease
Current Pharmaceutical Design Editorial : (Thematic issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II)
Current Medicinal Chemistry Exhaled Nitric Oxide as a Potential Biomarker of Continuous Positive Airway Pressure Therapy for Severe Obstructive Sleep Apnea Patients
Current Respiratory Medicine Reviews The Effect of Lead Exposure on Selected Blood Inflammatory Biomarkers in Guinea pigs
Cardiovascular & Hematological Disorders-Drug Targets Substitute and Add-on Devices Used in Inhalation Therapy: is it Safe to Recommend Replacing the Ventolin™ Actuator with the Sports-Haler™
Drug Delivery Letters Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Recent Patents on DNA & Gene Sequences Host Molecular Defense Mechanisms Against Chlamydophila pneumoniae and Genetic Studies of Immune-Response-Related Genes in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Impact of Altered Early Infant Gut Microbiota Following Breastfeeding and Delivery Mode on Allergic Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Emerging Nanocarriers-based Approaches to Diagnose and Red uce Vascular Inflammation in Atherosclerosis
Current Medicinal Chemistry The Use of Colchicine in Respiratory Diseases
Current Respiratory Medicine Reviews Preoperative Pulmonary Assessment: A Review
Current Respiratory Medicine Reviews Cytokine Antibody Arrays: A Promising Tool to Identify Molecular Targets for Drug Discovery
Combinatorial Chemistry & High Throughput Screening Fractions of <i>Boswellia Serrata</i> Suppress LTA<sub>4</sub>, LTC<sub>4</sub>, Cyclooxygenase-2 Activities and mRNA in HL-60 Cells and Reduce Lung Inflammation in BALB/c Mice
Current Drug Discovery Technologies Combination Therapy of Inhaled Corticosteroids and Long-Acting β2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Design